Scott Braunstein

(Dr. Scott Braunstein M.D.)

Currently holds positions in Trevena Inc, Protara Therapeutics Inc, ZIOPHARM Oncology Inc, Constellation Pharmaceuticals Inc and Marinus Pharmaceuticals Inc

Positions

Position Company Period
Director Trevena Inc Oct. 1, 2018 -
Director Protara Therapeutics Inc Jan. 9, 2020 -
Independent Director ZIOPHARM Oncology Inc Sept. 1, 2018 -
Independent Director Constellation Pharmaceuticals Inc Feb. 19, 2019 -
President, Chief Executive Officer, Director Marinus Pharmaceuticals Inc Aug. 12, 2019 -
Independent Director Esperion Therapeutics Inc Jan. 1, 2016 - March 14, 2020
Executive Chairman of the Board Marinus Pharmaceuticals Inc March 18, 2019 - Aug. 12, 2019
Independent Director Marinus Pharmaceuticals Inc Sept. 1, 2018 - March 18, 2019
Chief Operating Officer Pacira Biosciences Inc Dec. 11, 2017 - March 29, 2018
Senior Vice President - Strategy and Corporate Development Pacira Biosciences Inc July 14, 2015 - Dec. 11, 2017
Director Esperion Therapeutics Inc June 15, 2015 - Jan. 1, 2016
Scott Braunstein's trades of Marinus Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-08-07 2024-08-05 PS Planned sale
12,145 -3.9%
1.13
USD 13,724
12,145 -3.9% 1.13 USD 13,724
2024-02-21 2024-02-16 PS Planned sale
11,850 -5.0%
9.94
USD 117,789
11,850 -5.0% 9.94 USD 117,789
2023-08-08 2023-08-08 PS Planned sale
30 -0.0%
8.94
USD 268
30 -0.0% 8.94 USD 268
2023-08-08 2023-08-07 PS Planned sale
6,413 -3.8%
9.55
USD 61,244
6,413 -3.8% 9.55 USD 61,244
2019-12-13 2019-12-13 B Purchase
100,000 +inf%
1.25
USD 125,000
100,000 +inf% 1.25 USD 125,000
// ... existing code ... // ... rest of the file ...